INCY looks good!INCY
Very tight at the bottom of the box, low risk entry in the demand area. High profit potential
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.37 USD
32.62 M USD
4.24 B USD
190.58 M
About Incyte Corporation
Sector
Industry
CEO
Herve Hoppenot
Website
Headquarters
Wilmington
Founded
1991
FIGI
BBG000BNPSQ9
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Incyte Corp.Incyte Corp. witnessed a rebound after attempting to test the support level at 61.89, to close below the minor resistance 63.05, which is the level that needs to be violated to confirm the current positivity, which will trigger further rises near 62.65 - 65 - 65.61 - 66.43 - 67.40.
The stop-loss l
INCY setting up for a Base BreakoutINCY has been basing for a few months under this $66 level
Keep an eye out for the exit of the stage 1 base into a stage 2 breakout through $66 to the upside
INCY - Incyte Bullish BreakoutOn this 5 Month Daily Chart of Incyte you can clearly see the Bearish Trend that included the last 6 weeks of each daily candle trending below the 7 Day EMA until just the last 2 trading days where the bottom was made and INCY finally broke above the 7 day EMA on very good strenth with much higher v
INCY Buy Opportunity "Pause Rebounders "Pause Rebounder Stock
Market Watch:
Because until equity markets begin to notice. it’s unlikely politicians will feel compelled to act. Political brinkmanship will fuel market volatility — the VIX (VIX) trades to 40 in 2023; SPX retests the 3,800 floor. The similarities to 2011 (where arguably Dem
$INCY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $INCY after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 85.71%.
$INCY with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $INCY after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
WATCH $INCY CUP AND HANDLEBullish
Fundamental
- High inflationary Macro environment / still no fear form retail sentiment
- Decent Accumulation/Distribution
- Decent PE
- Decent PEG
- Decent P/FCF
- Top Sector / Industry
- Fundamental sound company with a Cup and handle play / short term
Technical
- Momentum Theory Indi
INCY - Bearish ActionI expect INCY to show bearish traits following this post
As price moves along the bearish red trend line
This bearish action may stop along the dotted white line, this would be the better entry for INCY
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where INCY is featured.
Related stocks
Frequently Asked Questions
The current price of INCY is 63.31 USD — it has increased by 0.73% in the past 24 hours. Watch Incyte Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Incyte Corporation stocks are traded under the ticker INCY.
INCY stock has risen by 5.40% compared to the previous week, the month change is a 8.23% rise, over the last year Incyte Corporation has showed a 11.34% increase.
We've gathered analysts' opinions on Incyte Corporation future price: according to them, INCY price has a max estimate of 96.00 USD and a min estimate of 52.00 USD. Watch INCY chart and read a more detailed Incyte Corporation stock forecast: see what analysts think of Incyte Corporation and suggest that you do with its stocks.
INCY reached its all-time high on Mar 15, 2017 with the price of 153.15 USD, and its all-time low was 1.66 USD and was reached on Sep 22, 1994. View more price dynamics on INCY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INCY stock is 1.20% volatile and has beta coefficient of 0.41. Track Incyte Corporation stock price on the chart and check out the list of the most volatile stocks — is Incyte Corporation there?
Today Incyte Corporation has the market capitalization of 12.15 B, it has increased by 2.12% over the last week.
Yes, you can track Incyte Corporation financials in yearly and quarterly reports right on TradingView.
Incyte Corporation is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
INCY earnings for the last quarter are 1.16 USD per share, whereas the estimation was 0.98 USD resulting in a 18.55% surprise. The estimated earnings for the next quarter are 1.40 USD per share. See more details about Incyte Corporation earnings.
Incyte Corporation revenue for the last quarter amounts to 1.05 B USD, despite the estimated figure of 985.11 M USD. In the next quarter, revenue is expected to reach 1.15 B USD.
INCY net income for the last quarter is 158.20 M USD, while the quarter before that showed 201.21 M USD of net income which accounts for −21.37% change. Track more Incyte Corporation financial stats to get the full picture.
No, INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 16, 2025, the company has 2.62 K employees. See our rating of the largest employees — is Incyte Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Incyte Corporation EBITDA is 296.13 M USD, and current EBITDA margin is 3.99%. See more stats in Incyte Corporation financial statements.
Like other stocks, INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Incyte Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Incyte Corporation technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Incyte Corporation stock shows the sell signal. See more of Incyte Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.